Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Michael Navato

Psychiatry Independence, MO Medical Doctor

NPI 1235337668 CMS profile 147272

3445 M 291 Hwy #300, Independence, MO 64057

Open in the dashboard

General payments

$79,630

317 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Michael Navato of Independence, MO is reported in the CMS Open Payments database as having received $79,630 across 317 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $18,369 99
2020 General $23,486 103
2019 General $37,774 115

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Navato
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Michael Navato were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Michael Navato Psychiatry median Middle half National median
2019 $37,774 $184 $59–$605 $163
2020 $23,486 $119 $36–$372 $114
2021 $18,369 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Alkermes, Inc. $46,655 83 payments
  2. Teva Pharmaceuticals USA, Inc. $30,589 53 payments
  3. Janssen Pharmaceuticals, Inc $437 30 payments
  4. Vanda Pharmaceuticals Inc. $373 23 payments
  5. ITI, Inc. $369 18 payments
  6. Sunovion Pharmaceuticals Inc. $312 59 payments
  7. Supernus Pharmaceuticals, Inc. $154 3 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $102 8 payments
  9. Lundbeck LLC $101 6 payments
  10. Otsuka America Pharmaceutical, Inc. $87 5 payments
  11. Other $451 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $67,050 36 payments
  2. Travel and Lodging $7,373 15 payments
  3. Food and Beverage $5,048 264 payments
  4. Education $158 2 payments
Products named General payments · program years 2019–2021
  1. ARISTADA INITIO $46,655 83 payments
  2. ARISTADA Cns $46,655 83 payments
  3. ARISTADA Cns $46,655 83 payments
  4. ARISTADA Cns $46,655 83 payments
  5. ARISTADA Cns $46,655 83 payments
  6. AUSTEDO $30,477 52 payments
  7. SPRAVATO $378 24 payments
  8. HETLIOZ $373 23 payments
  9. FANAPT $373 23 payments
  10. CAPLYTA $369 18 payments
  11. Other $1,453 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

317 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record